retatrutide trial results weight loss VisualAbstract: reduces body by 17.5% in patients with obesity Retatrutide phase 3 obesity trial
Description
Yellow Card Report a side effect or safety concern
Each treatment brings an immediate tightening effect and then over the next few months you see your skin continue to improve
Body weight was significantly reduced in both groups, although a greater reduction was seen with exenatide (lixisenatide 2.96 kg versus exenatide 3.98 kg
Always consult a doctor before starting any medicine
J Pers Med 12:454 Richard JE, Anderberg RH, Lpez-Ferreras L et al (2016) Sex and estrogens alter the action of glucagon-like peptide-1 on reward
Repurposing GLP-1 receptor agonists for parkinson's disease: current evidence and future opportunities
